Article
Sendai virus transgene in a novel gene therapy for laryngotracheal disease
10 May 2013
Abstract excerpt
OBJECTIVES/HYPOTHESIS: Vocal cord scar formation and laryngotracheal stenosis (LTS) are challenging problems for otolaryngologists. Sendai virus (SeV) vectors have been shown to transduce airway epithelium efficiently, and are thus ideal for modulating airway wound-healing therapy. To assess the potential utility of SeV gene therapy for laryngotracheal diseases, we established a novel LTS model and examined the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
